APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Animal Immunoglobulin G

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Animal Immunoglobulin G Market Outlook and Growth Opportunities 2026

Report ID 173964080430 December 2025214 pages

Choose your research edition.

Industry ResearchAnimal Immunoglobulin G Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Immunoglobulin G Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Animal Immunoglobulin G Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Immunoglobulin G Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Immunoglobulin G Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Animal Immunoglobulin G market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Animal Immunoglobulin G is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal Immunoglobulin G is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Immunoglobulin G is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Animal Immunoglobulin G market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Animal Immunoglobulin G market include Yuangu Bio, Yeasen, Beyotime Biotechnology, Vector Laboratories, Inc., Thermo Fisher Scientific Inc., SouthernBiotech, Sino Biological, Inc., Scripps Laboratories and Santa Cruz Biotechnology Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Animal Immunoglobulin G market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Immunoglobulin G and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Immunoglobulin G sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal Immunoglobulin G market size, projected growth trends, production technologies, key applications, and end-use industries.

Animal Immunoglobulin G Segment by Company

Yuangu Bio

Yeasen

Beyotime Biotechnology

Vector Laboratories, Inc.

Thermo Fisher Scientific Inc.

SouthernBiotech

Sino Biological, Inc.

Scripps Laboratories

Santa Cruz Biotechnology Inc.

Rockland Immunochemicals, Inc.

R&D Systems, Inc.

Proteintech Group, Inc.

MyBioSource

MP Biomedicals

Merck KGaA

Innovative Research

GenScript

GeneTex, Inc.

Fortis Life Sciences

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

Abcam Limited

Animal Immunoglobulin G Segment by Type

Cows

Goats and Sheeps

Rabbits

Mice and Rats

Other Animals

Animal Immunoglobulin G Segment by Application

Vaccine Development

Drug Development

Disease Detection

Others

Animal Immunoglobulin G Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Animal Immunoglobulin G status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Animal Immunoglobulin G market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal Immunoglobulin G significant trends, drivers, influence factors in global and regions.

6. To analyze Animal Immunoglobulin G competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Immunoglobulin G market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Immunoglobulin G and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Immunoglobulin G.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Animal Immunoglobulin G market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Immunoglobulin G industry.

Chapter 3: Detailed analysis of Animal Immunoglobulin G manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Animal Immunoglobulin G in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Animal Immunoglobulin G in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal Immunoglobulin G Industry Trends Table 2. Animal Immunoglobulin G Industry Drivers Table 3. Animal Immunoglobulin G Industry Opportunities and Challenges Table 4. Animal Immunoglobulin G Industry Restraints Table 5. Global Animal Immunoglobulin G Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal Immunoglobulin G Revenue Share by Company (2021-2026) Table 7. Global Animal Immunoglobulin G Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Animal Immunoglobulin G Sales Volume Share by Company (2021-2026) Table 9. Global Animal Immunoglobulin G Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Animal Immunoglobulin G Company Ranking, (2024-2026) & (USD Million) Table 11. Global Animal Immunoglobulin G Key Company Manufacturing Base & Headquarters Table 12. Global Animal Immunoglobulin G Company, Product Type & Application Table 13. Global Animal Immunoglobulin G Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Animal Immunoglobulin G by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Cows Table 18. Significant Companies of Goats and Sheeps Table 19. Significant Companies of Rabbits Table 20. Significant Companies of Mice and Rats Table 21. Significant Companies of Other Animals Table 22. Global Animal Immunoglobulin G Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 23. Global Animal Immunoglobulin G Sales Volume by Type (2021-2026) & (Kg) Table 24. Global Animal Immunoglobulin G Sales Volume by Type (2027-2032) & (Kg) Table 25. Global Animal Immunoglobulin G Sales Volume Share by Type (2021-2026) Table 26. Global Animal Immunoglobulin G Sales Volume Share by Type (2027-2032) Table 27. Global Animal Immunoglobulin G Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Animal Immunoglobulin G Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Animal Immunoglobulin G Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Animal Immunoglobulin G Sales Value Share by Type (2021-2026) Table 31. Global Animal Immunoglobulin G Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Vaccine Development Table 33. Significant Companies of Drug Development Table 34. Significant Companies of Disease Detection Table 35. Significant Companies of Others Table 36. Global Animal Immunoglobulin G Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 37. Global Animal Immunoglobulin G Sales Volume by Application (2021-2026) & (Kg) Table 38. Global Animal Immunoglobulin G Sales Volume by Application (2027-2032) & (Kg) Table 39. Global Animal Immunoglobulin G Sales Volume Share by Application (2021-2026) Table 40. Global Animal Immunoglobulin G Sales Volume Share by Application (2027-2032) Table 41. Global Animal Immunoglobulin G Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Animal Immunoglobulin G Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Animal Immunoglobulin G Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Animal Immunoglobulin G Sales Value Share by Application (2021-2026) Table 45. Global Animal Immunoglobulin G Sales Value Share by Application (2027-2032) Table 46. Global Animal Immunoglobulin G Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 47. Global Animal Immunoglobulin G Sales by Region (2021-2026) & (Kg) Table 48. Global Animal Immunoglobulin G Sales Market Share by Region (2021-2026) Table 49. Global Animal Immunoglobulin G Sales by Region (2027-2032) & (Kg) Table 50. Global Animal Immunoglobulin G Sales Market Share by Region (2027-2032) Table 51. Global Animal Immunoglobulin G Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Animal Immunoglobulin G Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Animal Immunoglobulin G Sales Value Share by Region (2021-2026) Table 54. Global Animal Immunoglobulin G Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Animal Immunoglobulin G Sales Value Share by Region (2027-2032) Table 56. Global Animal Immunoglobulin G Market Average Price (US$/Kg) by Region (2021-2026) Table 57. Global Animal Immunoglobulin G Market Average Price (US$/Kg) by Region (2027-2032) Table 58. Global Animal Immunoglobulin G Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 59. Global Animal Immunoglobulin G Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Animal Immunoglobulin G Sales by Country (2021-2026) & (Kg) Table 61. Global Animal Immunoglobulin G Sales Market Share by Country (2021-2026) Table 62. Global Animal Immunoglobulin G Sales by Country (2027-2032) & (Kg) Table 63. Global Animal Immunoglobulin G Sales Market Share by Country (2027-2032) Table 64. Global Animal Immunoglobulin G Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Animal Immunoglobulin G Sales Value Market Share by Country (2021-2026) Table 66. Global Animal Immunoglobulin G Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Animal Immunoglobulin G Sales Value Market Share by Country (2027-2032) Table 68. Yuangu Bio Company Information Table 69. Yuangu Bio Business Overview Table 70. Yuangu Bio Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Yuangu Bio Animal Immunoglobulin G Product Portfolio Table 72. Yuangu Bio Recent Development Table 73. Yeasen Company Information Table 74. Yeasen Business Overview Table 75. Yeasen Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Yeasen Animal Immunoglobulin G Product Portfolio Table 77. Yeasen Recent Development Table 78. Beyotime Biotechnology Company Information Table 79. Beyotime Biotechnology Business Overview Table 80. Beyotime Biotechnology Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Beyotime Biotechnology Animal Immunoglobulin G Product Portfolio Table 82. Beyotime Biotechnology Recent Development Table 83. Vector Laboratories, Inc. Company Information Table 84. Vector Laboratories, Inc. Business Overview Table 85. Vector Laboratories, Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Vector Laboratories, Inc. Animal Immunoglobulin G Product Portfolio Table 87. Vector Laboratories, Inc. Recent Development Table 88. Thermo Fisher Scientific Inc. Company Information Table 89. Thermo Fisher Scientific Inc. Business Overview Table 90. Thermo Fisher Scientific Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Thermo Fisher Scientific Inc. Animal Immunoglobulin G Product Portfolio Table 92. Thermo Fisher Scientific Inc. Recent Development Table 93. SouthernBiotech Company Information Table 94. SouthernBiotech Business Overview Table 95. SouthernBiotech Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. SouthernBiotech Animal Immunoglobulin G Product Portfolio Table 97. SouthernBiotech Recent Development Table 98. Sino Biological, Inc. Company Information Table 99. Sino Biological, Inc. Business Overview Table 100. Sino Biological, Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Sino Biological, Inc. Animal Immunoglobulin G Product Portfolio Table 102. Sino Biological, Inc. Recent Development Table 103. Scripps Laboratories Company Information Table 104. Scripps Laboratories Business Overview Table 105. Scripps Laboratories Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Scripps Laboratories Animal Immunoglobulin G Product Portfolio Table 107. Scripps Laboratories Recent Development Table 108. Santa Cruz Biotechnology Inc. Company Information Table 109. Santa Cruz Biotechnology Inc. Business Overview Table 110. Santa Cruz Biotechnology Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Santa Cruz Biotechnology Inc. Animal Immunoglobulin G Product Portfolio Table 112. Santa Cruz Biotechnology Inc. Recent Development Table 113. Rockland Immunochemicals, Inc. Company Information Table 114. Rockland Immunochemicals, Inc. Business Overview Table 115. Rockland Immunochemicals, Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Rockland Immunochemicals, Inc. Animal Immunoglobulin G Product Portfolio Table 117. Rockland Immunochemicals, Inc. Recent Development Table 118. R&D Systems, Inc. Company Information Table 119. R&D Systems, Inc. Business Overview Table 120. R&D Systems, Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. R&D Systems, Inc. Animal Immunoglobulin G Product Portfolio Table 122. R&D Systems, Inc. Recent Development Table 123. Proteintech Group, Inc. Company Information Table 124. Proteintech Group, Inc. Business Overview Table 125. Proteintech Group, Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 126. Proteintech Group, Inc. Animal Immunoglobulin G Product Portfolio Table 127. Proteintech Group, Inc. Recent Development Table 128. MyBioSource Company Information Table 129. MyBioSource Business Overview Table 130. MyBioSource Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 131. MyBioSource Animal Immunoglobulin G Product Portfolio Table 132. MyBioSource Recent Development Table 133. MP Biomedicals Company Information Table 134. MP Biomedicals Business Overview Table 135. MP Biomedicals Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 136. MP Biomedicals Animal Immunoglobulin G Product Portfolio Table 137. MP Biomedicals Recent Development Table 138. Merck KGaA Company Information Table 139. Merck KGaA Business Overview Table 140. Merck KGaA Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 141. Merck KGaA Animal Immunoglobulin G Product Portfolio Table 142. Merck KGaA Recent Development Table 143. Innovative Research Company Information Table 144. Innovative Research Business Overview Table 145. Innovative Research Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 146. Innovative Research Animal Immunoglobulin G Product Portfolio Table 147. Innovative Research Recent Development Table 148. GenScript Company Information Table 149. GenScript Business Overview Table 150. GenScript Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 151. GenScript Animal Immunoglobulin G Product Portfolio Table 152. GenScript Recent Development Table 153. GeneTex, Inc. Company Information Table 154. GeneTex, Inc. Business Overview Table 155. GeneTex, Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 156. GeneTex, Inc. Animal Immunoglobulin G Product Portfolio Table 157. GeneTex, Inc. Recent Development Table 158. Fortis Life Sciences Company Information Table 159. Fortis Life Sciences Business Overview Table 160. Fortis Life Sciences Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 161. Fortis Life Sciences Animal Immunoglobulin G Product Portfolio Table 162. Fortis Life Sciences Recent Development Table 163. Bio-Rad Laboratories, Inc. Company Information Table 164. Bio-Rad Laboratories, Inc. Business Overview Table 165. Bio-Rad Laboratories, Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 166. Bio-Rad Laboratories, Inc. Animal Immunoglobulin G Product Portfolio Table 167. Bio-Rad Laboratories, Inc. Recent Development Table 168. Agilent Technologies, Inc. Company Information Table 169. Agilent Technologies, Inc. Business Overview Table 170. Agilent Technologies, Inc. Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 171. Agilent Technologies, Inc. Animal Immunoglobulin G Product Portfolio Table 172. Agilent Technologies, Inc. Recent Development Table 173. Abcam Limited Company Information Table 174. Abcam Limited Business Overview Table 175. Abcam Limited Animal Immunoglobulin G Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 176. Abcam Limited Animal Immunoglobulin G Product Portfolio Table 177. Abcam Limited Recent Development Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Animal Immunoglobulin G Distributors List Table 181. Animal Immunoglobulin G Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Animal Immunoglobulin G Product Image Figure 2. Global Animal Immunoglobulin G Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Immunoglobulin G Sales Value (2021-2032) & (US$ Million) Figure 4. Global Animal Immunoglobulin G Sales (2021-2032) & (Kg) Figure 5. Global Animal Immunoglobulin G Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Animal Immunoglobulin G Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Cows Image Figure 10. Goats and Sheeps Image Figure 11. Rabbits Image Figure 12. Mice and Rats Image Figure 13. Other Animals Image Figure 14. Global Animal Immunoglobulin G Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global Animal Immunoglobulin G Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Animal Immunoglobulin G Sales Volume Share by Type (2021-2032) Figure 17. Global Animal Immunoglobulin G Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Animal Immunoglobulin G Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Animal Immunoglobulin G Sales Value Share by Type (2021-2032) Figure 20. Vaccine Development Image Figure 21. Drug Development Image Figure 22. Disease Detection Image Figure 23. Others Image Figure 24. Global Animal Immunoglobulin G Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 25. Global Animal Immunoglobulin G Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Animal Immunoglobulin G Sales Volume Share by Application (2021-2032) Figure 27. Global Animal Immunoglobulin G Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Animal Immunoglobulin G Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Animal Immunoglobulin G Sales Value Share by Application (2021-2032) Figure 30. Global Animal Immunoglobulin G Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 31. Global Animal Immunoglobulin G Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Animal Immunoglobulin G Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Animal Immunoglobulin G Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Animal Immunoglobulin G Sales Value (2021-2032) & (US$ Million) Figure 35. North America Animal Immunoglobulin G Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Animal Immunoglobulin G Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Animal Immunoglobulin G Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Animal Immunoglobulin G Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Animal Immunoglobulin G Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Animal Immunoglobulin G Sales Value (2021-2032) & (US$ Million) Figure 41. South America Animal Immunoglobulin G Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Animal Immunoglobulin G Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Animal Immunoglobulin G Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Animal Immunoglobulin G Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Animal Immunoglobulin G Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Animal Immunoglobulin G Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Cows
  • Goats and Sheeps
  • Rabbits
  • Mice and Rats
  • Other Animals
Applications
  • Vaccine Development
  • Drug Development
  • Disease Detection
  • Others
Companies covered
  • Yuangu Bio
  • Yeasen
  • Beyotime Biotechnology
  • Vector Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • SouthernBiotech
  • Sino Biological, Inc.
  • Scripps Laboratories
  • Santa Cruz Biotechnology Inc.
  • Rockland Immunochemicals, Inc.
  • R&D Systems, Inc.
  • Proteintech Group, Inc.
  • MyBioSource
  • MP Biomedicals
  • Merck KGaA
  • Innovative Research
  • GenScript
  • GeneTex, Inc.
  • Fortis Life Sciences
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Abcam Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Animal Immunoglobulin G Sales Value (2021-2032)
  4. 1.2.2 Global Animal Immunoglobulin G Sales Volume (2021-2032)
  5. 1.2.3 Global Animal Immunoglobulin G Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Animal Immunoglobulin G Market Dynamics
  1. 2.1 Animal Immunoglobulin G Industry Trends
  2. 2.2 Animal Immunoglobulin G Industry Drivers
  3. 2.3 Animal Immunoglobulin G Industry Opportunities and Challenges
  4. 2.4 Animal Immunoglobulin G Industry Restraints
3 Animal Immunoglobulin G Market by Company
  1. 3.1 Global Animal Immunoglobulin G Company Revenue Ranking in 2025
  2. 3.2 Global Animal Immunoglobulin G Revenue by Company (2021-2026)
  3. 3.3 Global Animal Immunoglobulin G Sales Volume by Company (2021-2026)
  4. 3.4 Global Animal Immunoglobulin G Average Price by Company (2021-2026)
  5. 3.5 Global Animal Immunoglobulin G Company Ranking (2024-2026)
  6. 3.6 Global Animal Immunoglobulin G Company Manufacturing Base and Headquarters
  7. 3.7 Global Animal Immunoglobulin G Company Product Type and Application
  8. 3.8 Global Animal Immunoglobulin G Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Animal Immunoglobulin G Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Animal Immunoglobulin G Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Animal Immunoglobulin G Market by Type
  1. 4.1 Animal Immunoglobulin G Type Introduction
  2. 4.1.1 Cows
  3. 4.1.2 Goats and Sheeps
  4. 4.1.3 Rabbits
  5. 4.1.4 Mice and Rats
  6. 4.1.5 Other Animals
  7. 4.2 Global Animal Immunoglobulin G Sales Volume by Type
  8. 4.2.1 Global Animal Immunoglobulin G Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Animal Immunoglobulin G Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Animal Immunoglobulin G Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Animal Immunoglobulin G Sales Value by Type
  12. 4.3.1 Global Animal Immunoglobulin G Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Animal Immunoglobulin G Sales Value by Type (2021-2032)
  14. 4.3.3 Global Animal Immunoglobulin G Sales Value Share by Type (2021-2032)
5 Animal Immunoglobulin G Market by Application
  1. 5.1 Animal Immunoglobulin G Application Introduction
  2. 5.1.1 Vaccine Development
  3. 5.1.2 Drug Development
  4. 5.1.3 Disease Detection
  5. 5.1.4 Others
  6. 5.2 Global Animal Immunoglobulin G Sales Volume by Application
  7. 5.2.1 Global Animal Immunoglobulin G Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Animal Immunoglobulin G Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Animal Immunoglobulin G Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Animal Immunoglobulin G Sales Value by Application
  11. 5.3.1 Global Animal Immunoglobulin G Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Animal Immunoglobulin G Sales Value by Application (2021-2032)
  13. 5.3.3 Global Animal Immunoglobulin G Sales Value Share by Application (2021-2032)
6 Animal Immunoglobulin G Regional Sales and Value Analysis
  1. 6.1 Global Animal Immunoglobulin G Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Immunoglobulin G Sales by Region (2021-2032)
  3. 6.2.1 Global Animal Immunoglobulin G Sales by Region: 2021-2026
  4. 6.2.2 Global Animal Immunoglobulin G Sales by Region (2027-2032)
  5. 6.3 Global Animal Immunoglobulin G Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Animal Immunoglobulin G Sales Value by Region (2021-2032)
  7. 6.4.1 Global Animal Immunoglobulin G Sales Value by Region: 2021-2026
  8. 6.4.2 Global Animal Immunoglobulin G Sales Value by Region (2027-2032)
  9. 6.5 Global Animal Immunoglobulin G Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Animal Immunoglobulin G Sales Value (2021-2032)
  12. 6.6.2 North America Animal Immunoglobulin G Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Animal Immunoglobulin G Sales Value (2021-2032)
  15. 6.7.2 Europe Animal Immunoglobulin G Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Animal Immunoglobulin G Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Animal Immunoglobulin G Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Animal Immunoglobulin G Sales Value (2021-2032)
  21. 6.9.2 South America Animal Immunoglobulin G Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Animal Immunoglobulin G Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Animal Immunoglobulin G Sales Value Share by Country, 2025 VS 2032
7 Animal Immunoglobulin G Country-level Sales and Value Analysis
  1. 7.1 Global Animal Immunoglobulin G Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal Immunoglobulin G Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Animal Immunoglobulin G Sales by Country (2021-2032)
  4. 7.3.1 Global Animal Immunoglobulin G Sales by Country (2021-2026)
  5. 7.3.2 Global Animal Immunoglobulin G Sales by Country (2027-2032)
  6. 7.4 Global Animal Immunoglobulin G Sales Value by Country (2021-2032)
  7. 7.4.1 Global Animal Immunoglobulin G Sales Value by Country (2021-2026)
  8. 7.4.2 Global Animal Immunoglobulin G Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Animal Immunoglobulin G Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Animal Immunoglobulin G Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Animal Immunoglobulin G Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuangu Bio
  2. 8.1.1 Yuangu Bio Company Information
  3. 8.1.2 Yuangu Bio Business Overview
  4. 8.1.3 Yuangu Bio Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yuangu Bio Animal Immunoglobulin G Product Portfolio
  6. 8.1.5 Yuangu Bio Recent Developments
  7. 8.2 Yeasen
  8. 8.2.1 Yeasen Company Information
  9. 8.2.2 Yeasen Business Overview
  10. 8.2.3 Yeasen Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yeasen Animal Immunoglobulin G Product Portfolio
  12. 8.2.5 Yeasen Recent Developments
  13. 8.3 Beyotime Biotechnology
  14. 8.3.1 Beyotime Biotechnology Company Information
  15. 8.3.2 Beyotime Biotechnology Business Overview
  16. 8.3.3 Beyotime Biotechnology Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beyotime Biotechnology Animal Immunoglobulin G Product Portfolio
  18. 8.3.5 Beyotime Biotechnology Recent Developments
  19. 8.4 Vector Laboratories, Inc.
  20. 8.4.1 Vector Laboratories, Inc. Company Information
  21. 8.4.2 Vector Laboratories, Inc. Business Overview
  22. 8.4.3 Vector Laboratories, Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Vector Laboratories, Inc. Animal Immunoglobulin G Product Portfolio
  24. 8.4.5 Vector Laboratories, Inc. Recent Developments
  25. 8.5 Thermo Fisher Scientific Inc.
  26. 8.5.1 Thermo Fisher Scientific Inc. Company Information
  27. 8.5.2 Thermo Fisher Scientific Inc. Business Overview
  28. 8.5.3 Thermo Fisher Scientific Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Scientific Inc. Animal Immunoglobulin G Product Portfolio
  30. 8.5.5 Thermo Fisher Scientific Inc. Recent Developments
  31. 8.6 SouthernBiotech
  32. 8.6.1 SouthernBiotech Company Information
  33. 8.6.2 SouthernBiotech Business Overview
  34. 8.6.3 SouthernBiotech Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SouthernBiotech Animal Immunoglobulin G Product Portfolio
  36. 8.6.5 SouthernBiotech Recent Developments
  37. 8.7 Sino Biological, Inc.
  38. 8.7.1 Sino Biological, Inc. Company Information
  39. 8.7.2 Sino Biological, Inc. Business Overview
  40. 8.7.3 Sino Biological, Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sino Biological, Inc. Animal Immunoglobulin G Product Portfolio
  42. 8.7.5 Sino Biological, Inc. Recent Developments
  43. 8.8 Scripps Laboratories
  44. 8.8.1 Scripps Laboratories Company Information
  45. 8.8.2 Scripps Laboratories Business Overview
  46. 8.8.3 Scripps Laboratories Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Scripps Laboratories Animal Immunoglobulin G Product Portfolio
  48. 8.8.5 Scripps Laboratories Recent Developments
  49. 8.9 Santa Cruz Biotechnology Inc.
  50. 8.9.1 Santa Cruz Biotechnology Inc. Company Information
  51. 8.9.2 Santa Cruz Biotechnology Inc. Business Overview
  52. 8.9.3 Santa Cruz Biotechnology Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Santa Cruz Biotechnology Inc. Animal Immunoglobulin G Product Portfolio
  54. 8.9.5 Santa Cruz Biotechnology Inc. Recent Developments
  55. 8.10 Rockland Immunochemicals, Inc.
  56. 8.10.1 Rockland Immunochemicals, Inc. Company Information
  57. 8.10.2 Rockland Immunochemicals, Inc. Business Overview
  58. 8.10.3 Rockland Immunochemicals, Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Rockland Immunochemicals, Inc. Animal Immunoglobulin G Product Portfolio
  60. 8.10.5 Rockland Immunochemicals, Inc. Recent Developments
  61. 8.11 R&D Systems, Inc.
  62. 8.11.1 R&D Systems, Inc. Company Information
  63. 8.11.2 R&D Systems, Inc. Business Overview
  64. 8.11.3 R&D Systems, Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 R&D Systems, Inc. Animal Immunoglobulin G Product Portfolio
  66. 8.11.5 R&D Systems, Inc. Recent Developments
  67. 8.12 Proteintech Group, Inc.
  68. 8.12.1 Proteintech Group, Inc. Company Information
  69. 8.12.2 Proteintech Group, Inc. Business Overview
  70. 8.12.3 Proteintech Group, Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Proteintech Group, Inc. Animal Immunoglobulin G Product Portfolio
  72. 8.12.5 Proteintech Group, Inc. Recent Developments
  73. 8.13 MyBioSource
  74. 8.13.1 MyBioSource Company Information
  75. 8.13.2 MyBioSource Business Overview
  76. 8.13.3 MyBioSource Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 MyBioSource Animal Immunoglobulin G Product Portfolio
  78. 8.13.5 MyBioSource Recent Developments
  79. 8.14 MP Biomedicals
  80. 8.14.1 MP Biomedicals Company Information
  81. 8.14.2 MP Biomedicals Business Overview
  82. 8.14.3 MP Biomedicals Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 MP Biomedicals Animal Immunoglobulin G Product Portfolio
  84. 8.14.5 MP Biomedicals Recent Developments
  85. 8.15 Merck KGaA
  86. 8.15.1 Merck KGaA Company Information
  87. 8.15.2 Merck KGaA Business Overview
  88. 8.15.3 Merck KGaA Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Merck KGaA Animal Immunoglobulin G Product Portfolio
  90. 8.15.5 Merck KGaA Recent Developments
  91. 8.16 Innovative Research
  92. 8.16.1 Innovative Research Company Information
  93. 8.16.2 Innovative Research Business Overview
  94. 8.16.3 Innovative Research Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Innovative Research Animal Immunoglobulin G Product Portfolio
  96. 8.16.5 Innovative Research Recent Developments
  97. 8.17 GenScript
  98. 8.17.1 GenScript Company Information
  99. 8.17.2 GenScript Business Overview
  100. 8.17.3 GenScript Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 GenScript Animal Immunoglobulin G Product Portfolio
  102. 8.17.5 GenScript Recent Developments
  103. 8.18 GeneTex, Inc.
  104. 8.18.1 GeneTex, Inc. Company Information
  105. 8.18.2 GeneTex, Inc. Business Overview
  106. 8.18.3 GeneTex, Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 GeneTex, Inc. Animal Immunoglobulin G Product Portfolio
  108. 8.18.5 GeneTex, Inc. Recent Developments
  109. 8.19 Fortis Life Sciences
  110. 8.19.1 Fortis Life Sciences Company Information
  111. 8.19.2 Fortis Life Sciences Business Overview
  112. 8.19.3 Fortis Life Sciences Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Fortis Life Sciences Animal Immunoglobulin G Product Portfolio
  114. 8.19.5 Fortis Life Sciences Recent Developments
  115. 8.20 Bio-Rad Laboratories, Inc.
  116. 8.20.1 Bio-Rad Laboratories, Inc. Company Information
  117. 8.20.2 Bio-Rad Laboratories, Inc. Business Overview
  118. 8.20.3 Bio-Rad Laboratories, Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Bio-Rad Laboratories, Inc. Animal Immunoglobulin G Product Portfolio
  120. 8.20.5 Bio-Rad Laboratories, Inc. Recent Developments
  121. 8.21 Agilent Technologies, Inc.
  122. 8.21.1 Agilent Technologies, Inc. Company Information
  123. 8.21.2 Agilent Technologies, Inc. Business Overview
  124. 8.21.3 Agilent Technologies, Inc. Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Agilent Technologies, Inc. Animal Immunoglobulin G Product Portfolio
  126. 8.21.5 Agilent Technologies, Inc. Recent Developments
  127. 8.22 Abcam Limited
  128. 8.22.1 Abcam Limited Company Information
  129. 8.22.2 Abcam Limited Business Overview
  130. 8.22.3 Abcam Limited Animal Immunoglobulin G Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Abcam Limited Animal Immunoglobulin G Product Portfolio
  132. 8.22.5 Abcam Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Animal Immunoglobulin G Value Chain Analysis
  2. 9.1.1 Animal Immunoglobulin G Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Animal Immunoglobulin G Sales Mode & Process
  6. 9.2 Animal Immunoglobulin G Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Animal Immunoglobulin G Distributors
  9. 9.2.3 Animal Immunoglobulin G Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst